These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 22807676)
1. Hyperthermia stimulates HIV-1 replication. Roesch F; Meziane O; Kula A; Nisole S; Porrot F; Anderson I; Mammano F; Fassati A; Marcello A; Benkirane M; Schwartz O PLoS Pathog; 2012; 8(7):e1002792. PubMed ID: 22807676 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of Heat Shock Protein 90 Prevents HIV Rebound. Joshi P; Maidji E; Stoddart CA J Biol Chem; 2016 May; 291(19):10332-46. PubMed ID: 26957545 [TBL] [Abstract][Full Text] [Related]
3. SAMHD1 Impairs HIV-1 Gene Expression and Negatively Modulates Reactivation of Viral Latency in CD4 Antonucci JM; Kim SH; St Gelais C; Bonifati S; Li TW; Buzovetsky O; Knecht KM; Duchon AA; Xiong Y; Musier-Forsyth K; Wu L J Virol; 2018 Aug; 92(15):. PubMed ID: 29793958 [TBL] [Abstract][Full Text] [Related]
4. NUCKS1, a novel Tat coactivator, plays a crucial role in HIV-1 replication by increasing Tat-mediated viral transcription on the HIV-1 LTR promoter. Kim HY; Choi BS; Kim SS; Roh TY; Park J; Yoon CH Retrovirology; 2014 Aug; 11():67. PubMed ID: 25116364 [TBL] [Abstract][Full Text] [Related]
5. Naf1 Regulates HIV-1 Latency by Suppressing Viral Promoter-Driven Gene Expression in Primary CD4+ T Cells. Li C; Wang HB; Kuang WD; Ren XX; Song ST; Zhu HZ; Li Q; Xu LR; Guo HJ; Wu L; Wang JH J Virol; 2017 Jan; 91(1):. PubMed ID: 27795436 [TBL] [Abstract][Full Text] [Related]
6. A lentiviral vector that activates latent human immunodeficiency virus-1 proviruses by the overexpression of tat and that kills the infected cells. Macías D; Oya R; Saniger L; Martín F; Luque F Hum Gene Ther; 2009 Nov; 20(11):1259-68. PubMed ID: 19604078 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of HIV-1 reactivation by a telomerase-derived peptide in a HSP90-dependent manner. Kim H; Choi MS; Inn KS; Kim BJ Sci Rep; 2016 Jul; 6():28896. PubMed ID: 27363520 [TBL] [Abstract][Full Text] [Related]
8. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication. McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770 [TBL] [Abstract][Full Text] [Related]
10. Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3. Sarracino A; Gharu L; Kula A; Pasternak AO; Avettand-Fenoel V; Rouzioux C; Bardina M; De Wit S; Benkirane M; Berkhout B; Van Lint C; Marcello A mBio; 2018 Nov; 9(6):. PubMed ID: 30425153 [TBL] [Abstract][Full Text] [Related]
11. Long Noncoding RNA uc002yug.2 Activates HIV-1 Latency through Regulation of mRNA Levels of Various RUNX1 Isoforms and Increased Tat Expression. Huan C; Li Z; Ning S; Wang H; Yu XF; Zhang W J Virol; 2018 May; 92(9):. PubMed ID: 29491162 [TBL] [Abstract][Full Text] [Related]
12. LGIT In Vitro Latency Model in Primary and T Cell Lines to Test HIV-1 Reactivation Compounds. Jung U; Takahashi M; Rossi JJ; Burnett JC Methods Mol Biol; 2016; 1354():255-64. PubMed ID: 26714717 [TBL] [Abstract][Full Text] [Related]
13. Shutdown of HIV-1 Transcription in T Cells by Nullbasic, a Mutant Tat Protein. Jin H; Li D; Sivakumaran H; Lor M; Rustanti L; Cloonan N; Wani S; Harrich D mBio; 2016 Jul; 7(4):. PubMed ID: 27381288 [TBL] [Abstract][Full Text] [Related]
14. Repressive LTR nucleosome positioning by the BAF complex is required for HIV latency. Rafati H; Parra M; Hakre S; Moshkin Y; Verdin E; Mahmoudi T PLoS Biol; 2011 Nov; 9(11):e1001206. PubMed ID: 22140357 [TBL] [Abstract][Full Text] [Related]
15. Interplay between viral Tat protein and c-Jun transcription factor in controlling LTR promoter activity in different human immunodeficiency virus type I subtypes. van der Sluis RM; Derking R; Breidel S; Speijer D; Berkhout B; Jeeninga RE J Gen Virol; 2014 Apr; 95(Pt 4):968-979. PubMed ID: 24447950 [TBL] [Abstract][Full Text] [Related]
16. The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency. Mousseau G; Kessing CF; Fromentin R; Trautmann L; Chomont N; Valente ST mBio; 2015 Jul; 6(4):e00465. PubMed ID: 26152583 [TBL] [Abstract][Full Text] [Related]
17. Tumor suppressor cylindromatosis (CYLD) controls HIV transcription in an NF-κB-dependent manner. Manganaro L; Pache L; Herrmann T; Marlett J; Hwang Y; Murry J; Miorin L; Ting AT; König R; García-Sastre A; Bushman FD; Chanda SK; Young JA; Fernandez-Sesma A; Simon V J Virol; 2014 Jul; 88(13):7528-40. PubMed ID: 24760882 [TBL] [Abstract][Full Text] [Related]
18. Quiescence Promotes Latent HIV Infection and Resistance to Reactivation from Latency with Histone Deacetylase Inhibitors. Painter MM; Zaikos TD; Collins KL J Virol; 2017 Dec; 91(24):. PubMed ID: 29021396 [TBL] [Abstract][Full Text] [Related]
19. Effects of HCV on basal and tat-induced HIV LTR activation. Sengupta S; Powell E; Kong L; Blackard JT PLoS One; 2013; 8(6):e64956. PubMed ID: 23762271 [TBL] [Abstract][Full Text] [Related]
20. HIV-1 Tat endocytosis and retention in endolysosomes affects HIV-1 Tat-induced LTR transactivation in astrocytes. Khan N; Halcrow PW; Afghah Z; Baral A; Geiger JD; Chen X FASEB J; 2022 Mar; 36(3):e22184. PubMed ID: 35113458 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]